Factor VIII Concentrate powder bulk supplier for pharma manufacturers

Factor VIII Concentrate Powder Suppliers & Bulk Manufacturers

Available Forms: Lyophilized (freeze-dried) powder

Available Strengths: 250 IU, 500 IU, 1000 IU, 2000 IU vials

Reference Brands: Hemofil M, Kogenate FS, Advate (US); Kogenate, Octanate (EU)

Factor VIII concentrate, plasma-derived or recombinant, as lyophilised powder in 250 to 2000 IU vials for haemophilia A. For haemophilia centres, hospital pharmacies, importers and tender buyers needing cold-chain biological supply.

Get Enquiry / Request Bulk Quote

Usually answered within 48 hours | GMP documents shared before you commit

Manufacture or export Factor VIII Concentrate Powder? List it or send an offer →

Product Description:

Factor VIII is the clotting protein missing or faulty in haemophilia A, and concentrates replace it so a stable clot can form again. Plasma-derived concentrates are purified from pooled human plasma with viral inactivation steps, and some also contain von Willebrand factor. Recombinant concentrates are made in cell lines, as full-length or B-domain-modified molecules, some with extended half-life. All come as lyophilised powder in 250, 500, 1000 or 2000 IU vials with diluent and a transfer device. Potency is assigned in international units against the WHO standard.

Factor VIII controls bleeding in haemophilia A, covers surgery and, above all, is given as regular prophylaxis to keep levels above the bleeding threshold. Some plasma-derived products with von Willebrand factor are also used in von Willebrand disease. Doses are calculated from body weight and the target rise, given by slow intravenous injection. The main clinical issue is inhibitor development, so patients new to treatment are tested regularly. Batch numbers are recorded for every dose. It is on the WHO essential medicines list.

Sourcing notes. Factor VIII concentrates are prescription-only biological medicines. Many authorities require lot release by the national control laboratory, or accept another authority's release certificate, before each lot is sold. For plasma-derived products ask for the plasma master file or origin statement and viral safety data. For all products request the batch CoA, GMP certificate and CoPP. The cold chain is 2 to 8 °C without freezing; many labels allow a limited room-temperature period. State product type, vial strengths, device format and minimum shelf life.

Factor VIII Concentrate Powder — third party manufacturing & bulk supply

Factor VIII Concentrate Powder is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:

Wholesale / bulk supply Stock or scheduled supply from an existing manufacturer. The fastest route where the product is already registered in your market.

Third party manufacturing Manufactured to your specification and packed under your own brand and label — suits distributors and brand owners building a portfolio in their market.

Dossier licensing Where a CTD, EU-CTD or ACTD dossier exists it can often be licensed for filing in your name, compressing market entry from years to months.

Indicative minimum order quantity

Factor VIII Concentrate Powder is supplied as Lyophilized (freeze-dried) powder — an injectable dosage form, so the indicative MOQ is 50,000 units. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.

Manufacturers of Factor VIII Concentrate Powder listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding.

Request a quote for Factor VIII Concentrate Powder →

Usually answered within 48 hours, with matched manufacturers, indicative prices and document status.

Back to Listing

Frequently Asked Questions

Factor VIII Concentrate powder is used to treat and prevent bleeding episodes in patients with hemophilia A, a genetic bleeding disorder caused by a deficiency of clotting Factor VIII. It is also used to control bleeding during surgeries or injuries in patients with this condition.

Factor VIII Concentrate powder is produced either from purified human plasma or through recombinant DNA technology. It contains coagulation Factor VIII, a protein that plays a vital role in the blood clotting process.

Common trade names include Advate, Adynovate, Eloctate, Afstyla, Kovaltry, and NovoEight.

Factor VIII Concentrate products are manufactured by several pharmaceutical companies including Takeda, Bayer, CSL Behring, Novo Nordisk, Sanofi, and Pfizer depending on the specific brand.

The generic name is coagulation factor VIII or antihemophilic factor (recombinant).

Brand names include Advate (USA, EU, India, LATAM), Adynovate (USA, EU), Eloctate (USA, EU, global markets), Afstyla (USA, EU), Kovaltry (USA, EU, LATAM), and NovoEight (USA, EU, global markets).

Factor VIII Concentrate powder is manufactured in several countries including the United States, Germany, Denmark, Austria, and other European countries depending on the manufacturer and brand.